U.S. health officials said Monday Johnson & Johnson’s COVID-19 vaccine may pose a "small possible risk" of a rare neurological disorder known as Guillain-Barré syndrome, another setback for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results